"We are excited to expand our direct operations into the UK," said Jeffrey Burbank,
Chief Executive Officer of NxStage. "As the next step in our
international growth strategy, this move presents us with the
opportunity to build upon Kimal's success, strengthen our relationship
with customers, and more rapidly take advantage of new product
"Kimal are so proud of the introduction we have made in the UK
with the technology of NxStage. It is a delight to be able to make
such a difference to the lives of patients with renal disease," stated Alan Press, Chief Executive Officer of Kimal Plc.
"Dialysis keeps them alive, NxStage at home gives them their life
back! May many more patients receive this benefit, it really does make a
difference. We wish every success to the NxStage team."
NxStage team is solely dedicated to supporting home hemodialysis
enabling close alignment and responsiveness with the needs of UK Trusts, health care professionals, and patients. NxStage UK
will set up and directly control commercial activities including sales,
marketing, and all clinical support activities for the National Health
Service (NHS) hospitals managing home hemodialysis programs.
Source: NxStage Medical